Developments in the prescription drug market: oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016
Publisher
U.S. Government Publishing Office
Publication Date
2017.
Language
English
Description
Loading Description...
Also in this Series
Checking series information...
Subjects
Subjects
Corrupt practices
Drug approval
Drug approval -- United States
Generic drugs
Generic drugs -- Government policy -- United States
Government policy
Legislative hearings
Pharmaceutical industry
Pharmaceutical industry -- Corrupt practices -- United States
Prescription pricing
Prescription pricing -- United States
Drug approval
Drug approval -- United States
Generic drugs
Generic drugs -- Government policy -- United States
Government policy
Legislative hearings
Pharmaceutical industry
Pharmaceutical industry -- Corrupt practices -- United States
Prescription pricing
Prescription pricing -- United States
Staff View
Loading Staff View.